ROR1 expression is not a unique marker of CLL

被引：59
作者：
Barna, Gabor [1 ]
Mihalik, Rudolf [1 ,2 ]
Timar, Botond [1 ]
Toemboel, Judit [1 ]
Csende, Zsolt [3 ]
Sebestyen, Anna [1 ]
Boedoer, Csaba [1 ]
Csernus, Balazs [1 ]
Reiniger, Lilla [1 ]
Petak, Istvan [1 ,2 ]
Matolcsy, Andras [1 ]
机构：
[1] Semmelweis Univ, Fac Med, Dept Pathol & Expt Canc Res 1, H-1085 Budapest, Hungary
[2] Semmelweis Univ, Cooperat Res Ctr, H-1085 Budapest, Hungary
[3] Fac Med, Dept Biomech, Budapest, Hungary
来源：
HEMATOLOGICAL ONCOLOGY | 2011年 / 29卷 / 01期
关键词：
CLL; MCL; MZL; ROR1; Wnt; lymphoma; CHRONIC LYMPHOCYTIC-LEUKEMIA; RECEPTOR TYROSINE KINASE; GENE-EXPRESSION; HUMAN CANCER; B-CELLS; MUTATIONS; SCREEN; PROGRESSION; ACTIVATION; PHENOTYPE;
D O I：
10.1002/hon.948
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Recent studies have identified receptor tyrosine kinase-like orphan receptor 1 (ROR1) on the surface of chronic lymphoid leukaemia (CLL) cells. In order to determine whether ROR1 expression is a suitable surrogate marker for the diagnosis of CLL we analysed the mRNA level of ROR1 in different types of non-Hodgkin lymphomas (NHL), and detected elevated levels of ROR1 compared to control peripheral mononuclear cells in several entities (CLL >= mantle cell lymphoma (MCL) > marginal zone lymphoma (MZL)>> diffuse large B-cell lymphoma > follicular lymphoma). ROR1 protein was expressed intensely on the cell surface of lymphoma cells with leukaemic blood count detected by three colour immunofluorescence. Our results indicate that ROR1 expression is not limited to CLL cases, but it is more prevalent in NHLs, mainly in MCL where it is expressed intensely and MZL where it is expressed moderately, suggesting a general role of ROR1 in lymphoma genesis and/or maintenance. Copyright (C) 2010 John Wiley & Sons, Ltd.
引用
收藏
页码：17 / 21
页数：5
相关论文
共 27 条
  • [1] Mutational analysis of the tyrosine kinome in colorectal cancers
    Bardelli, A
    Parsons, DW
    Silliman, N
    Ptak, J
    Szabo, S
    Saha, S
    Markowitz, S
    Willson, JKV
    Parmigiani, G
    Kinzler, KW
    Vogelstein, B
    Velculescu, VE
    [J]. SCIENCE, 2003, 300 (5621) : 949 - 949
  • [2] Unique cell surface expression of receptor tyrosine kinase ROR1 in human B-cell chronic lymphocytic leukemia
    Baskar, Sivasubramanian
    Kwong, Kayin
    Hofer, Thomas
    Levy, Jessica M.
    Kennedy, Michael G.
    Lee, Elinor
    Staudt, Louis M.
    Wilson, Wyndham H.
    Wiestner, Adrian
    Rader, Christoph
    [J]. CLINICAL CANCER RESEARCH, 2008, 14 (02) : 396 - 404
  • [3] Systematic genomic screen for tyrosine kinase mutations in CLL
    Brown, J. R.
    Levine, R. L.
    Thompson, C.
    Basile, G.
    Gilliland, D. G.
    Freedman, A. S.
    [J]. LEUKEMIA, 2008, 22 (10) : 1966 - 1969
  • [4] Ror1, a cell surface receptor tyrosine kinase is expressed in chronic lymphocytic leukemia and may serve as a putative target for therapy
    DaneshManesh, Amir H.
    Mikaelsson, Eva
    Jeddi-Tehrani, Mahmood
    Bayat, Ali Ahmad
    Ghods, Roya
    Ostadkarampour, Mahyar
    Akhondi, Mehdi
    Lagercrantz, Svetlana
    Larsson, Catharina
    Osterborg, Anders
    Shokri, Fazel
    Mellstedt, Hakan
    Rabbani, Hodjattallah
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2008, 123 (05) : 1190 - 1195
  • [5] Wnt expression and canonical Wnt signaling in human bone marrow B lymphopoiesis
    Dosen, Guri
    Tenstad, Ellen
    Nygren, Marit Kveine
    Stubberud, Heidi
    Funderud, Steinar
    Rian, Edith
    [J]. BMC IMMUNOLOGY, 2006, 7 (1)
  • [6] Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal,antigen and receptor for Wnt5a
    Fukuda, Tetsuya
    Chen, Liguang
    Endo, Tomoyuki
    Tang, Li
    Lu, Desheng
    Castro, Jariuario E.
    Widhopf, George F., II
    Rassenti, Laura Z.
    Cantwell, Mark J.
    Prussak, Charles E.
    Carson, Dennis A.
    Kipps, Thomas J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (08) : 3047 - 3052
  • [7] Somatic hypermutation of IGVH genes and aberrant somatic hypermutation in follicular lymphoma without BCL-2 gene rearrangement and expression
    Gagyi, Eva
    Balogh, Zsofia
    Boedoer, Csaba
    Timar, Botond
    Reiniger, Lilla
    Deak, Linda
    Csomor, Judit
    Csernus, Balazs
    Szepesi, Agota
    Matolcsy, Andras
    [J]. HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 (12): : 1822 - 1828
  • [8] Constitutive activation of the Wnt canonical pathway in mantle cell lymphoma
    Gelebart, Pascal
    Anand, Mona
    Armanious, Hanan
    Peters, Anthea C.
    Bard, Jennifer Dien
    Amin, Hesham M.
    Lai, Raymond
    [J]. BLOOD, 2008, 112 (13) : 5171 - 5179
  • [9] Ror receptor tyrosine kinases: orphans no more
    Green, Jennifer L.
    Kuntz, Steven G.
    Sternberg, Paul W.
    [J]. TRENDS IN CELL BIOLOGY, 2008, 18 (11) : 536 - 544
  • [10] Patterns of somatic mutation in human cancer genomes
    Greenman, Christopher
    Stephens, Philip
    Smith, Raffaella
    Dalgliesh, Gillian L.
    Hunter, Christopher
    Bignell, Graham
    Davies, Helen
    Teague, Jon
    Butler, Adam
    Edkins, Sarah
    O'Meara, Sarah
    Vastrik, Imre
    Schmidt, Esther E.
    Avis, Tim
    Barthorpe, Syd
    Bhamra, Gurpreet
    Buck, Gemma
    Choudhury, Bhudipa
    Clements, Jody
    Cole, Jennifer
    Dicks, Ed
    Forbes, Simon
    Gray, Kris
    Halliday, Kelly
    Harrison, Rachel
    Hills, Katy
    Hinton, Jon
    Jenkinson, Andy
    Jones, David
    Menzies, Andy
    Mironenko, Tatiana
    Perry, Janet
    Raine, Keiran
    Richardson, Dave
    Shepherd, Rebecca
    Small, Alexandra
    Tofts, Calli
    Varian, Jennifer
    Webb, Tony
    West, Sofie
    Widaa, Sara
    Yates, Andy
    Cahill, Daniel P.
    Louis, David N.
    Goldstraw, Peter
    Nicholson, Andrew G.
    Brasseur, Francis
    Looijenga, Leendert
    Weber, Barbara L.
    Chiew, Yoke-Eng
    [J]. NATURE, 2007, 446 (7132) : 153 - 158
123